PureTech Health (PTCHF) Stock Price, News & Analysis

Company Overview

PureTech Health plc is a biopharmaceutical company that develops medicines for complex diseases, with a focus on therapeutic approaches designed to address significant unmet patient needs. The company combines its own research and development activities with a model of creating, financing and advancing subsidiary companies that pursue distinct therapeutic programs.

PureTech’s research platform includes orally administered medicines and other treatments intended to influence biological pathways that are difficult to target with conventional drug-delivery methods. Its pipeline has included candidates for conditions involving the brain, immune system, respiratory system and lymphatic system, including programs based on the company’s lymphatic-targeting and gut-brain axis technologies. Programs and development priorities may change as clinical and regulatory work progresses.

Historically, PureTech has helped establish and develop biotechnology businesses, including Karuna Therapeutics, which was acquired by Bristol Myers Squibb in 2023. PureTech operates internationally, with activities and personnel in the United States and the United Kingdom. The company was founded by Daphne Zohar, who serves as its chief executive officer.

Key Stats

• Today's Range: $1.51 to $1.51
• 50-Day Range: $1.51 to $1.65
• 52-Week Range: $1.45 to $1.92
• Volume: N/A
• Average Volume: 34,122 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:PTCHF
• CIK: 1782999
• Web: www.puretechhealth.com
• Phone: (617) 482-2333
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A